A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Ethicon Releases Statement on Resumption of Elective Surgery

ETHICON Supports Sages Guidelines for Surgery Amid COVID-19 Pandemic As Parts of the United States Begin to Resume Elective Surgery

Ethicon*, part of the Johnson & Johnson Medical Device Companies**, and one of the world’s leading manufacturers of surgical devices, announced its continued support of guidelines from the Society for American Gastrointestinal and Endoscopic Surgeons (SAGES), which recommends the use of personal protective equipment (PPE) and smoke evacuation in the operating room during laparoscopic and open surgery.

Currently, there is no data on the transmission of SARS-COV-2 in surgical smoke during surgery.1 However, there is no indication or proof that SARS-COV-2 is not transmissible through surgical smoke.In fact, there is no conclusive evidence to indicate that use of electrosurgical or ultrasonic devices during surgery increases the risk of infectious disease transmission via surgical smoke.2 SAGES and AORN1 are providing recommendations to ensure the perioperative team takes measures to protect themselves from any potential unknown risk.1,3 Ethicon recommends the use of smoke evacuation to minimize the potential risk to surgical teams from potentially hazardous substances including cellular material, blood fragments, bacteria, viruses, toxic gases, vapors and chemical compounds4.

Each year, in America, approximately 500,000 OR personnel are exposed to surgical smoke5, with this number estimated to be double worldwide6. Surgical smoke can cause acute and chronic health effects ranging from eye, nose and throat irritation to emphysema, asthma and chronic bronchitis. 4,7

“We stand with the surgical and healthcare community during this unprecedented and challenging time,” said Raymond Fryrear, MD, VP & Integrated Leader, PreClinical, Clinical and Medical Affairs, Johnson & Johnson. “The safety and protection of hospital personnel and patients has always been our top priority. Our goal is that every hospital has access to smoke evacuation and energy products in an effort to make procedures safer for surgeons, nurses and the entire OR team.”

In early April, Ethicon released a letter to customers explaining its support of the SAGES surgical guidelines and describing the theoretical risk of COVID-19 transmission through surgical smoke. The company noted that COVID-19 particles range from 60-140 nanometers (nm) in diameter and generally disperse in the form of much larger water droplets. Smoke evacuators that use an ULPA filter, such as Ethicon’s MEGADYNE Smoke Evacuators, capture and filter at least 99.999954% of particulates and microorganisms sized 120nm. ULPA filter efficiency improves with particles both smaller and larger than the listed size rating (rating range of 100-200nm). 8

In addition to SAGES, smoke evacuation in the OR is recommended by industry associations including the Association of periOperative Registered Nurses (AORN),1 and the National Institute for Occupational Safety and Health (NIOSH).6


References

1 AORN – COVID-19 FAQs [https://www.aorn.org/guidelines/aorn-support/covid19-faqs] Accessed 4/30/2020
2 Morris SN, et al. Understanding the “Scope” of the Problem: Why Laparoscopy is Considered Safe During the COVID-19 Pandemic. J Minim Invasive Gynecol. 2020 Apr 2. [Epub ahead of print]
3 SAGES Resources for Smoke & Gas Evacuation During Open, Laparoscopic, and Endoscopic Procedures [https://www.aorn.org/guidelines/aorn-support/covid19-faqs]. Accessed 4/30/2020.
4 Okoshi K, et al. Health risks associated with exposure to surgical smoke for surgeons and operation room personnel. Surg Today. 2015 Aug;45(8):957-65. Epub 2014 Nov 25.
5 OSHA – Laser Hazards [https://www.osha.gov/SLTC/laserhazards/]. Accessed 05/08/2020.
6 Memon AG, Naeem Z, Zaman A, Zahid F (2016) Occupational health related concerns among surgeons. Int J Health Sci 10 (2): 279-291.
7 CDC – NIOSH Study Finds Healthcare Workers’ Exposure to Surgical Smoke Still Common [https://www.cdc.gov/niosh/updates/upd-11-03-15.html] Accessed: April 30, 2020
8 ISO – High efficiency filters and filter media for removing particles from air. Part 1: Classification, performance, testing and marking. ISO 29463-1. Second edition, 2017-09

SourceEthicon
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.
Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines

By using this website you agree to accept Medical Device News Magazine Privacy Policy